Acorda Therapeutics Inc (NASDAQ:ACOR)

25.35
Delayed Data
As of 10:21am ET
 +0.05 / +0.20%
Today’s Change
13.60
Today|||52-Week Range
33.00
+18.18%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Scopia Capital Management Lp
Buy8/29/2017500,000$19.05$9.5M+30.08%
Scopia Capital Management Lp
Buy8/29/2017150,000$19.52$2.9M+30.08%
Scopia Capital Management Lp
Buy8/29/2017116,201$19.62$2.3M+30.08%
Wasman Jane
President-International & General Counsel
Sale1/19/201834,170$27.58$942.4K-6.99%
Lawrence David /acorda/
Sale1/19/201829,918$27.58$825.1K-6.99%
Wasman Jane
President-International & General Counsel
Buy1/19/201834,520$19.81$683.8K-6.99%
Lawrence David /acorda/
Buy1/19/201830,418$19.81$602.6K-6.99%
Cohen Ronald
President & Chief Executive Officer
Buy6/16/201720,000$16.95$339.0K+46.67%
Blank Burkhard
Chief Medical Officer
Sale12/01/201711,050$20.53$226.9K+21.63%
Randall Lorin Jeffry
Director
Sale7/31/201710,000$21.66$216.6K+16.86%
Page of 4